Ashton Thomas Private Wealth, LLC Plus Therapeutics, Inc. Transaction History

Ashton Thomas Private Wealth, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Apr 19, 2024	SELL	$1.17 - $3.16 $14,309 - $38,646	-12,230 Closed	0 $0
Q2 2023 Apr 22, 2024	SELL	$0.23 - $4.91 $2,812 - $60,049	-12,230 Closed	0 $0
Q1 2023 Apr 22, 2024	BUY	$0.27 - $0.48 $3,302 - $5,870	12,230 New	12,230 $3.55 Million
Q2 2022 Apr 19, 2024	BUY	$0.46 - $1.02 $5,625 - $12,474	12,230 New	12,230 $6.61 Million

Ticker PSTV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,601,400
Market Cap $52.1M
Description
Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer and other diseases. Its lead drug candidate is Rhenium-186 NanoLiposome, a patented radiotherapy that targets central nervous system cancers, including recurrent glioblastoma, lep...

Get notified when there are updates to the investment portfolio of Ashton Thomas Private Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Ashton Thomas Private Wealth, LLC with notifications on news.